NCCCNCCCCNCCCN.C([O-])(=[O:27])CCCCCCCCCCC.[Na+].[OH-].[Na+].CC(=CCC/C(=C/CO)/C)C.CCCCCCCCCCCCCCCC([O:60][CH2:61][CH:62]([OH:70])[C@H:63]1[O:67][CH2:66][C@H:65]([OH:68])[C@H:64]1[OH:69])=O>C(O)CCCCCCC>[O:27]=[CH:66][C@@H:65]([C@H:64]([C@@H:63]([C@@H:62]([CH2:61][OH:60])[OH:70])[OH:67])[OH:69])[OH:68]
A composition was prepared by dissolving human insulin with spermine and polyvinylpyrrolidone (PVP-40), sodium dodecanoate (SD) and methylcellulose (MC-400) in DDW containing NaOH. The solution was then lyophilized and suspended with octanol and geraniol in a mixture of medium chain triglyceride (MCT) oil and castor oil, further containing sorbitan monopalmitate (Span-40). Components and concentrations are detailed in Table 4.
読み込み中…
